GRP and neoplasm: Thus, imaging at later time points enables further increase of imaging contrast, and hence sensitivity, even for imaging probes with rapid in vivo kinetics and tumor targeting, such as bombesin analogues [38], somatostatin analogues [39], single chain variable fragments (scFv) [40], and affibody molecules [41].